Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $10.71 Analyst target: $12.86 Upside: 20.07%
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in Chicago, Illinois.
See the full interactive analysis & chart →Informational only — not investment advice.